Mechanical Insufflation -Exsufflation in Children With NMD and Weak Cough

NCT ID: NCT04081116

Last Updated: 2023-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

77 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-01

Study Completion Date

2021-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Neuromuscular diseases (NMD) in children are severe, possibly life-threatening orphan conditions. The children are vulnerable and often subject to rapid deterioration of pulmonary function due to impaired ability to clear airway secretions. The use of mechanical cough augmentation with insufflation-exsufflation (MIE) is a strategy to treat and prevent. Possible major benefits are described, but optimal settings for best efficacy and comfort in children are not established. The project aim to improve the quality of the treatment with MIE in children with NMD and weak cough. On the basis of a bench study a clinical trial aims to examine the most effective MIE settings when used in stable state and when respiratory tract infections are present.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

On the basis of a prevalence study and a bench study different settings will be studied in children with NMD and weak cough to examine if settings derived from the lung model, are optimal to increase the peak cough flow (PCF) and comfort measured by visual analogue scale (VAS) in children with NMD and weak cough.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuromuscular Diseases in Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Three different settings are tested on the same patients but in randomized order.
Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Participant, care provider, investigator and outcomes assessor are blinded from the order of the settings tested. Only a technician change settings and know the order.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MI-E testing symmetric settings

Symmetric settings is one of 3 different settings that will be tested on the same day but in randomized order.

Group Type EXPERIMENTAL

Symmetric settings (high pressures/fast rate)

Intervention Type OTHER

Describes settings on the MI-E device

Asymmetric settings (Pi<Pe/Ti>Te)

Intervention Type OTHER

Lower insufflation pressures at longer times

Preinclusion settings

Intervention Type OTHER

Settings in use at start of study

MI-E testing assymetric settings

Asymmetric settings is one of 3 different settings that will be tested on the same day but in randomized order.

Group Type EXPERIMENTAL

Symmetric settings (high pressures/fast rate)

Intervention Type OTHER

Describes settings on the MI-E device

Asymmetric settings (Pi<Pe/Ti>Te)

Intervention Type OTHER

Lower insufflation pressures at longer times

Preinclusion settings

Intervention Type OTHER

Settings in use at start of study

Settings in use

Settings in use is one of 3 different settings that will be tested on the same day but in randomized order

Group Type SHAM_COMPARATOR

Symmetric settings (high pressures/fast rate)

Intervention Type OTHER

Describes settings on the MI-E device

Asymmetric settings (Pi<Pe/Ti>Te)

Intervention Type OTHER

Lower insufflation pressures at longer times

Preinclusion settings

Intervention Type OTHER

Settings in use at start of study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Symmetric settings (high pressures/fast rate)

Describes settings on the MI-E device

Intervention Type OTHER

Asymmetric settings (Pi<Pe/Ti>Te)

Lower insufflation pressures at longer times

Intervention Type OTHER

Preinclusion settings

Settings in use at start of study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed neuromuscular disease \< 18 years
* Established use (\> 3mnd) of MI-E.
* Reduced PCF

* PCF \< 270 l/min (when \> 12 years)
* \< 5th percentiles for PCF 16 (when 4 - 12 years)
* Clinical indication (difficulty to clear secretions, audible weak cough, history of pneumonia or frequent or prolonged respiratory tract infections).

Exclusion Criteria

* age \< 6 mnd
* obstructive lung disease (hyperinflation or emphysema on x-ray.
Minimum Eligible Age

6 Months

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oslo University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Brit Hov

Physiotherapist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Helse bergen HF

Bergen, , Norway

Site Status

Oslo university hospital

Oslo, , Norway

Site Status

Stavanger university hospital

Stavanger, , Norway

Site Status

St. Olav Trondheim university hospital

Trondheim, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

References

Explore related publications, articles, or registry entries linked to this study.

Morrow B, Argent A, Zampoli M, Human A, Corten L, Toussaint M. Cough augmentation techniques for people with chronic neuromuscular disorders. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013170. doi: 10.1002/14651858.CD013170.pub2.

Reference Type DERIVED
PMID: 33887060 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18/12375

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CPAP for Infantile Pompe Disease
NCT02405624 UNKNOWN PHASE4